Kuros Biosciences received FDA 510(k) approval for its transforaminal lumbar interbody fusion cage.
What you should know:
1. Kuros developed the TLIF cage for use with its spinal fusion product candidate KUR-113. The FDA cleared the cage for use in the lumbar spine with autograft and/or allograft.
2. With the approval, Kuros will begin a clinical trial studying the two products in patients.
3. The TLIF cage comes in several sizes and includes instrumentation.